http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6241110-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2009-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7038b2e46dab20ad54e83c3bd575e11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1f6913a84ab1cceb4af51e26f4a7c41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e23412b8e351f8704c7eba394c60509b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11cb409fb5c13f0cada81810f03614a9
publicationDate 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-6241110-A2
titleOfInvention HETEROARILIC DEAMID ANALOGS AS P2X7 ANTAGONISTS
abstract or a pharmaceutically acceptable salt thereof, wherein: T, U and V are independently selected from CR3, CRA and N, such that (i) exactly one of T, U and V is CRA; and (ii) if X is CH2, Y is phenyl, and U and V are both substituted carbons, then T is not N; W is -C (= O) NR4-, -NR4C (= O) or NR4-NR4-C (= O) -; X is absent or is C1-C6 alkylene which is substituted with 0 to 4 substituents independently selected from: i) C1-C4 alkyl, (C1-C8 cycloalkyl) C0-C2 alkyl and C0-C2 phenylalkyl; ii) substituents which taken together to form a 3- to 7-membered cycloalkyl or heterocycloalkyl ring; and iii) substituents that are taken together with R4 to form a 4- to 7- membered heterocycloalkyl; and is C3-C16 cycloalkyl, 4- to 16-membered heterocycloalkyl, 6-to 16-membered aryl or 5-to 16-membered heteroaryl, each of which is substituted with 0 to 6 substituents independently selected from hydroxy, halogen, cyano, amino, nitro, oxo, aminocarbonyl, aminosulfonyl, COOH, C1-C6 alkyl, C2-C6 alkenyl, C2-C6a alkynyl, C1-C6 haloalkyl, C1-C6 hydroxyalkyl, C1-C6 aminoalkyl, C1-C6 alkoxy alkyl, C 1 -C 6 haloalkoxy, C 2 -C 6 alkyl ether, C 1 -C 6 alkanoyl, C 1 -C 6 alkylsulfonyl, (C 3 -C 7 cycloalkyl) C 0 -C 4 alkyl, mono- or di- (C 1 -C 6 alkyl) amino, C 1 -C 6 alkanoylamino, mono- or di- (C1-C6 alkyl) aminocarbonyl, mono or di (C1-C6 alkyl) aminosulfonyl and (C1-C6 alkyl) sulfonylamino; Z1 and Z3 are independently N or CR2; Z2 is N, CR2 or CRA; Each R2 and each R3 is independently selected from hydrogen, halogen, cyano, amino, nitro, aminocarbonyl, aminosulfonyl, COOH, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C1-C6 hydroxyalkyl, C1-C6 aminoalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkanoyl, C2-C6 alkyl ether, (C3-C7 cycloalkyl) C0-C4 alkyl, mono- or di- (C1-C6 alkyl) amino, C1-C6 alkylsulfonyl -C6, C1-C6 alkanoylamino, mono- or di- (C1-C6 alkyl) aminocarbonyl, mono- or di- (C1-C6 alkyl) aminosulfonyl and (C1-C6 alkyl) sulfonylamino; Each R4 is independently hydrogen, C1-C6 alkyl, (C3-C8 cycloalkyl) C0-C2 alkyl or ...
priorityDate 2007-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457584123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283

Total number of triples: 57.